- Easy-to-use platform
- Low fees
- Student and young investor discounts
Research stocks
Ready to invest in the medical industry? Consider these 11 stocks.
The best research stocks depend on your portfolio and investment goals — while volatility can be ideal for day traders, long-term investors will want to look to stocks with steadier gains over time.
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
Our picks for the best research stocks
We round up a selection of stocks in or related to the medical industry, weighting the list more heavily towards popular mid- and large-cap US stocks.1. Biocept (BIOC)
Biocept, Inc. , a molecular oncology diagnostics company, develops and commercializes proprietary clinical diagnostic laboratory assays designed to identify rare tumor cells and cell-free tumor DNA from blood and cerebrospinal fluid, or CSF in the United States. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring to identify resistance mechanisms.
- Previous close price: $0.03
- Market capitalization: $1,142,060
- 1 year performance: -75.93%
2. Opko Health (OPK)
OPKO Health, Inc. , a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test.
- Previous close price: $1.07
- Market capitalization: $759,721,280
- 1 year performance: -17.69%
3. Natera (NTRA)
Natera, Inc. , a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born.
- Previous close price: $90.46
- Market capitalization: $11,138,114,560
- 1 year performance: 62.46%
4. Danaher Corporation (DHR)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands.
- Previous close price: $248.77
- Market capitalization: $189,119,610,880
- 1 year performance: 1.62%
- P/E ratio: 45.3316
5. IDEXX Laboratories (IDXX)
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy.
- Previous close price: $539.57
- Market capitalization: $44,211,040,256
- 1 year performance: 11.65%
- P/E ratio: 52.8917
6. Co-Diagnostics (CODX)
Co-Diagnostics, Inc. , a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications.
- Previous close price: $1.11
- Market capitalization: $34,698,268
- 1 year performance: -41.58%
7. DexCom (DXCM)
DexCom, Inc. , a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers.
- Previous close price: $139.48
- Market capitalization: $51,092,303,872
- 1 year performance: 19.00%
- P/E ratio: 101.9462
8. Laboratory Corporation of America (LH)
Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests.
- Previous close price: $216.57
- Market capitalization: $18,213,537,792
- 1 year performance: -0.38%
- P/E ratio: 50.0162
9. Agilent Technologies (A)
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab.
- Previous close price: $147.37
- Market capitalization: $42,320,076,800
- 1 year performance: 9.54%
- P/E ratio: 34.6307
10. Illumina (ILMN)
Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments.
- Previous close price: $138.68
- Market capitalization: $21,260,820,480
- 1 year performance: N/A
11. Thermo Fisher Scientific (TMO)
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
- Previous close price: $579.37
- Market capitalization: $221,180,018,688
- 1 year performance: 4.00%
- P/E ratio: 37.5924
How to buy research stocks
- Compare online trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Use our comparison table to narrow down top brokers by fees and bonuses.
- Open and fund your account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for the stock you're interested in. Find the stock by name or ticker symbol, like BIOC or OPK. Research its history to confirm it's a solid investment against your financial goals.
- Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy fractional shares, depending on your broker.
- Buy the stock. Congratulations, you own a part of a research company. Optimize your portfolio by tracking how your stock — and even the sector as a whole — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Buy research stocks from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Note: The dollar amounts in the table below are in Canadian dollars.
Bottom line
While it's possible to turn a profit investing in research stocks, keep in mind that — like any investment — research stocks are not immune to risk. These stocks are subject to fluctuating conditions — both in the market and in the medical industry, so carefully vet your picks before you invest. And if you're new to investing, or if it's been awhile since you've taken a critical look at your investing accounts, compare brokers to make sure you're getting the best features in your trading account.More on investing
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…What are stocks?
Owning a stock means you own part of a company and can potentially grow your wealth. But there is a risk of loss.
Read more…More guides on Finder
-
How to buy Yoshitsu Co. stock in Canada
Steps to owning and managing Yoshitsu Co. stocks, with 24-hour and historical pricing before you buy.
-
How to buy Cerberus Cyber Sentinel stock in Canada
Steps to owning and managing Cerberus Cyber Sentinel stocks, with 24-hour and historical pricing before you buy.
-
How to buy Fresh Grapes LLC stock in Canada
Steps to owning and managing Fresh Vine Wine, Inc stocks, with 24-hour and historical pricing before you buy.
-
How to buy Quest Diagnostics Incorporated stock in Canada
Steps to owning and managing DGX with 24-hour and historical pricing before you buy.
-
How to buy Nuvectis Pharma (NVCT) stock in Canada when it goes public
Everything we know about the Nuvectis Pharma IPO plus information on how to buy in.
-
How to buy BuzzFeed stock in Canada
Steps to owning and managing BuzzFeed, Inc stocks, with 24-hour and historical pricing before you buy.
-
Best renewable energy stocks
These are the best renewable energy stocks to buy now in Canada.
-
How to buy ADMA Biologics stock in Canada
Steps to owning and managing ADMA with 24-hour and historical pricing before you buy.
-
How to buy Dycom Industries stock in Canada
Steps to owning and managing DY with 24-hour and historical pricing before you buy.
-
How to buy VICI Properties stock in Canada
Steps to owning and managing VICI with 24-hour and historical pricing before you buy.